Semaglutide
How WHO Graded Its Child Obesity Advice: Strong Rules, Thin Evidence
WHO's first child and adolescent obesity guidelines pair firm advice with thin proof. Here are the grades behind each rule, the conditions on teen drug treatment, and questions to bring to a pediatrician.
Compounding Pharmacies, Explained: Why 'FDA-Approved' Is a Lie
Compounding pharmacies aren't FDA-approved, because that approval doesn't exist for them. Here's the regulatory split behind the copycat-Ozempic crackdown, and why claiming otherwise just got 25 telehealth firms in trouble.
FDA's Compounded Semaglutide Ban, Explained: What Changes for Patients
The FDA's April 2026 proposal would end large-scale compounding of semaglutide and tirzepatide. Individual-patient compounding isn't affected, but the supply picture is about to shrink.
Semaglutide Slowed an Aging Marker 9% in HIV Trial, Study Finds
A trial in adults with HIV found semaglutide slowed one measure of biological aging by 9% versus placebo. Researchers call it an early signal, not evidence the drug reverses aging.